Trial intelligence / Profile preview

Topical mitomycin C after endoscopic dilatation for long caustic esophageal stricture in children

ACTRN12613001070729Phase 3Completed

Sponsor
Ain Shams University
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of mitomycin c in caustic esophageal stricture, sponsored by Ain Shams University. Primary endpoint: Percentage of patients with resolution of dysphagia. Started Jan 2009; status: completed.

02

Drugs

mitomycin c
03

Conditions

caustic esophageal stricture

Beyond the preview

Go deeper on ACTRN12613001070729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001070729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call